$LLY News

Eli Lilly Stock Fell 2.5% Ahead of Q3. Here’s Why Revenue Could Dip Even as Patients Grow

Eli Lilly (LLY) Reports Strong Phase 1 Ovarian Cancer Data

3 Massive Catalysts That Could Ignite an Eli Lilly Stock Rally on Oct 29

New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancer

Eli Lilly's Next-Generation Ovarian Cancer Drug Shows 79% Response Rate, 100% Disease Control In New Data

Lilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRα-targeting ADC at ESMO 2026

Q2 earnings highs and lows: Eli Lilly (NYSE:LLY) vs the rest of the branded pharmaceuticals stocks

Goldman Sachs resets Eli Lilly 12-month stock price target before earnings

Eli Lilly (LLY) Builds In Richmond As Fair Value Still Sits Higher

JP Morgan Expects Emerging Market Weight Loss Drug Sales To Reach $22 Billion

Polen Focus Growth Strategy Trims Eli Lilly and Company (LLY) While Maintaining Confidence in Its Outlook

Eli Lilly's Fast Growth Hasn't Slowed Its Progress As Sustainability Leader

What Sent Eli Lilly Stock Higher Over The Past Year?

Amgen vs. Eli Lilly: Does the GLP-1 Mania Make LLY Stock a Better Buy in 2026?

What Does Eli Lilly (LLY) Mean To Signal With Its $5 Billion Richmond Build?

Lilly breaks ground in Richmond to expand American manufacturing of next-generation cancer medicines, advancing its build-out of 10 new U.S. sites since 2020

Earnings Preview: Eli Lilly (LLY) Q3 Earnings Expected to Decline

Bristol Myers Squibb vs. Eli Lilly: How Long Can Zepbound and Mounjaro Keep Juicing Revenue Results?

Eli Lilly Starts Construction On $5B Production Site In Richmond, Virginia

Eli Lilly (LLY) Grew Revenue 48% While Prices Fell, Can Volume Keep Winning?